Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

New Market Research Report: Intarcia Therapeutics, Inc. - Product Pipeline Review - 2013


Print article Print article
2013-08-07 01:39:05 - Recently published research from Global Markets Direct, "Intarcia Therapeutics, Inc. - Product Pipeline Review - 2013", is now available at Fast Market Research

Global Markets Direct's pharmaceuticals report, "Intarcia Therapeutics, Inc. - Product Pipeline Review - 2013" provides data on the Intarcia Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Intarcia Therapeutics, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Intarcia Therapeutics, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Intarcia Therapeutics, Inc. - Brief Intarcia Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline

of Intarcia Therapeutics, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Intarcia Therapeutics, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Intarcia Therapeutics, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/666768_intarcia_therapeutics_inc_product_pip ..

Reasons to Get this Report

* Evaluate Intarcia Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Intarcia Therapeutics, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Intarcia Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Intarcia Therapeutics, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Intarcia Therapeutics, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Intarcia Therapeutics, Inc.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Intarcia Therapeutics, Inc. Snapshot
Intarcia Therapeutics, Inc. Overview
Key Information
Key Facts
Intarcia Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Intarcia Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Intarcia Therapeutics, Inc. - Pipeline Products Glance
Intarcia Therapeutics, Inc. - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Intarcia Therapeutics, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Intarcia Therapeutics, Inc. - Drug Profiles
exenatide
Product Description
Mechanism of Action
R&D Progress
ITCA-880
Product Description
Mechanism of Action
R&D Progress
ITCA-884
Product Description
Mechanism of Action
R&D Progress
Intarcia Therapeutics, Inc. - Pipeline Analysis
Intarcia Therapeutics, Inc. - Pipeline Products by Therapeutic Class
Intarcia Therapeutics, Inc. - Pipeline Products By Target
Intarcia Therapeutics, Inc. - Pipeline Products by Route of Administration
Intarcia Therapeutics, Inc. - Pipeline Products By Mechanism of Action
Intarcia Therapeutics, Inc. - Recent Pipeline Updates
Intarcia Therapeutics, Inc. - Dormant Projects
Intarcia Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Intarcia Therapeutics, Inc., Key Information
Intarcia Therapeutics, Inc., Key Facts
Intarcia Therapeutics, Inc. - Pipeline by Indication, 2013
Intarcia Therapeutics, Inc. - Pipeline by Stage of Development, 2013
Intarcia Therapeutics, Inc. - Monotherapy Products in Pipeline, 2013
Intarcia Therapeutics, Inc. - Phase III, 2013
Intarcia Therapeutics, Inc. - Phase I, 2013
Intarcia Therapeutics, Inc. - Pipeline By Therapeutic Class, 2013
Intarcia Therapeutics, Inc. - Pipeline By Target, 2013
Intarcia Therapeutics, Inc. - Pipeline By Route of Administration, 2013
Intarcia Therapeutics, Inc. - Pipeline Products By Mechanism of Action, 2013
Intarcia Therapeutics, Inc. - Recent Pipeline Updates, 2013
Intarcia Therapeutics, Inc. - Dormant Developmental Projects,2013

List of Figures
Intarcia Therapeutics, Inc. - Pipeline by Indication, 2013
Intarcia Therapeutics, Inc. - Pipeline by Stage of Development, 2013
Intarcia Therapeutics, Inc. - Monotherapy Products in Pipeline, 2013
Intarcia Therapeutics, Inc. - Pipeline By Therapeutic Class, 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com